3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase NA
1
Status
Unknown
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Stomach Neoplasms
3
Nutrition Disorders
1
Neoplasms
1
Gastroesophageal Reflux
1
Interventions
Oxaliplatin
56
Capecitabine
49
Fluorouracil
37
Cisplatin
37
S 1 (combination)
23
Paclitaxel
18
Docetaxel
18
Leucovorin
16
pembrolizumab
13
Irinotecan
12
apatinib
11
titanium silicide
9
XELOX
9
Trastuzumab
9
Nivolumab
9
Hyperthermic Intraperitoneal Chemotherapy
8
Epirubicin
8
Drug Therapy
8
Tegafur
7
Radiotherapy
6
Neoadjuvant Therapy
6
gimeracil
5
Surgical Procedures, Operative
5
Gastrectomy
5
Chemotherapy, Adjuvant
5
tislelizumab
4
S-1 plus cisplatin
4
Ramucirumab
4
zolbetuximab
3
sintilimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Stomach Neoplasms
×
Anastomosis, Roux-en-Y
×
Clear all
NCT06768164
2026-05-20
BYQoL-GC
Assistance Publique - Hôpitaux de Paris
Phase 3
Recruiting
250 enrolled
NCT02110628
2018-01-24
WCGCC-1202
West China Hospital
Phase 3
Unknown
588 enrolled
NCT01996059
2013-11-27
FJINS
Sun Yat-sen University
Phase 3
Unknown
500 enrolled